Adverse drug reactions in patients admitted on Internal Medicine wards in a district and Regional Hospital in Uganda

被引:0
作者
Tumwikirize, W. A. [1 ,2 ]
Ogwal-Okeng, J. W. [1 ]
Vernby, A. [2 ]
Anokbonggo, W. W. [1 ]
Gustafsson, L. L. [3 ]
Lundborg, S. C. [2 ]
机构
[1] Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda
[2] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth, Stockholm, Sweden
[3] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Lab Med,Div Clin Pharmacol, Stockholm, Sweden
关键词
Adverse drug reactions; medical wards; hospitalization; ADMISSIONS; COSTS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The burden of both community and hospital acquired adverse drug reactions (ADRs) are some of the important issues in pharmacotherapy. At the time of this study there was very scanty literature in this area from Africa. Objective: This study was done to determine the frequency and characteristics of ADRs in patients admitted on medical wards in public hospitals. Methods: This was a longitudinal observational study on 728 adult patients on medical wards in one regional and one district hospitals. Community and hospital acquired ADRs were assessed. Results: Thirty three patients (4.5%) were admitted with suspected ADR, and an ADR was the reason for hospitalization in 1.5%. Most ADRs were due to antiparasitic products, mainly quinine (61%). Community acquired ADRs prolonged hospital stay, 5.6 days vs 4.0 days (p-value < 0.001). During hospitalization ADRs occurred in 49.5% of the patients. Antiparasitic products, predominantly quinine, were the commonest drugs class associated with ADRs (85.9%). Hospital acquired ADRs did not affect hospital stay, 4.2 days vs 3.9 (p-value 0.129). Conclusion: ADRs are an important cause of morbidity in patients, both in the community and in hospitals, and the majority are associated with the commonly used drugs.
引用
收藏
页码:72 / 78
页数:7
相关论文
共 19 条
[1]  
[Anonymous], INT CLASS DIS VERS 1
[2]   Adverse drug reactions: a cohort study in internal medicine units at a university hospital [J].
Camargo, AL ;
Ferreira, MBC ;
Heineck, I .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (02) :143-149
[3]   Readmissions and adverse drug reactions in internal medicine:: the economic impact [J].
Dormann, H ;
Neubert, A ;
Criegee-Rieck, M ;
Egger, T ;
Radespiel-Tröger, M ;
Azaz-Livshits, T ;
Levy, M ;
Brune, K ;
Hahn, EG .
JOURNAL OF INTERNAL MEDICINE, 2004, 255 (06) :653-663
[4]   Incidence and costs of adverse drug reactions during hospitalisation - Computerised monitoring versus stimulated spontaneous reporting [J].
Dormann, H ;
Muth-Selbach, U ;
Krebs, S ;
Criegee-Rieck, M ;
Tegeder, I ;
Schneider, HT ;
Hahn, EG ;
Levy, M ;
Brune, K ;
Geisslinger, G .
DRUG SAFETY, 2000, 22 (02) :161-168
[5]   HARMONIZATION IN PHARMACOVIGILANCE [J].
EDWARDS, IR ;
BIRIELL, C .
DRUG SAFETY, 1994, 10 (02) :93-102
[6]   Factors associated with preventability, predictability, and severity of adverse drug reactions [J].
Gholami, K ;
Shalviri, G .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (02) :236-240
[7]   DRUG RELATED ADMISSIONS TO MEDICAL WARDS - A POPULATION BASED SURVEY [J].
HALLAS, J ;
GRAM, LF ;
GRODUM, E ;
DAMSBO, N ;
BROSEN, K ;
HAGHFELT, T ;
HARVALD, B ;
BECKNIELSEN, J ;
WORM, J ;
JENSEN, KB ;
DAVIDSEN, O ;
FRANDSEN, NE ;
HAGEN, C ;
ANDERSEN, M ;
FROLUND, F ;
KROMANNANDERSEN, H ;
SCHOU, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (01) :61-68
[8]   Adverse drug reactions in a department of systemic diseases-oriented internal medicine:: prevalence, incidence, direct costs and avoidability [J].
Lagnaoui, R ;
Moore, N ;
Fach, J ;
Longy-Boursier, M ;
Bégaud, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (02) :181-186
[9]   Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].
Lazarou, J ;
Pomeranz, BH ;
Corey, PN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205
[10]  
MEHTA U, BR J CLIN PHARM, V65, P396